Cargando…
The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome
BACKGROUND: Women with polycystic ovary syndrome (PCOS) are characterized by increased cardiometabolic risk. The aim of the current study was to compare the impact of atorvastatin on plasma levels of cardiometabolic risk factors between men whose sisters had either PCOS or were unaffected. METHODS:...
Autores principales: | Krysiak, Robert, Szkróbka, Witold, Okopień, Bogusław |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149333/ https://www.ncbi.nlm.nih.gov/pubmed/32696349 http://dx.doi.org/10.1007/s43440-020-00135-w |
Ejemplares similares
-
Correction to: The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome
por: Krysiak, Robert, et al.
Publicado: (2021) -
Impaired Prolactin-Lowering Effects of Metformin in Women with Polycystic Ovary Syndrome
por: Krysiak, Robert, et al.
Publicado: (2023) -
Vitamin D Status Determines Cardiometabolic Effects of Cabergoline in Women with Elevated Prolactin Levels: A Pilot Study
por: Krysiak, Robert, et al.
Publicado: (2023) -
The impact of hypotestosteronemia on cardiometabolic effects of atorvastatin in men with hypercholesterolemia: a pilot study
por: Krysiak, Robert, et al.
Publicado: (2021) -
Vitamin D Status Determines the Impact of Metformin on Gonadotropin Levels in Postmenopausal Women
por: Krysiak, Robert, et al.
Publicado: (2023)